BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20048177)

  • 1. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma.
    Al-Mansour M; Connors JM; Gascoyne RD; Skinnider B; Savage KJ
    J Clin Oncol; 2010 Feb; 28(5):793-9. PubMed ID: 20048177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
    Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group.
    Biasoli I; Stamatoullas A; Meignin V; Delmer A; Reman O; Morschhauser F; Coiffier B; Bosly A; Diviné M; Brice P
    Cancer; 2010 Feb; 116(3):631-9. PubMed ID: 20029973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
    J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome.
    Larouche JF; Berger F; Chassagne-Clément C; Ffrench M; Callet-Bauchu E; Sebban C; Ghesquières H; Broussais-Guillaumot F; Salles G; Coiffier B
    J Clin Oncol; 2010 Apr; 28(12):2094-100. PubMed ID: 20308668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases.
    Vang R; Medeiros LJ; Ha CS; Deavers M
    Mod Pathol; 2000 Jan; 13(1):19-28. PubMed ID: 10658906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodular lymphocyte predominant Hodgkin's lymphoma.
    Siddiqui N; Al-Diab AI
    Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
    Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
    J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy.
    Advani R; Rosenberg SA; Horning SJ
    J Clin Oncol; 2004 Apr; 22(8):1454-9. PubMed ID: 15024027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.
    Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO;
    Leuk Lymphoma; 2003 Nov; 44(11):1903-10. PubMed ID: 14738141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.
    Validire P; Capovilla M; Asselain B; Kirova Y; Goudefroye R; Plancher C; Fourquet A; Zanni M; Gaulard P; Vincent-Salomon A; Decaudin D
    Am J Hematol; 2009 Mar; 84(3):133-9. PubMed ID: 19199367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
    Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1326-34. PubMed ID: 17162215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Gobbi PG; Angrilli F; Brugiatelli M; Musto P; Federico M
    Haematologica; 2008 Sep; 93(9):1335-42. PubMed ID: 18698083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology.
    Hartmann S; Eray M; Döring C; Lehtinen T; Brunnberg U; Kujala P; Vornanen M; Hansmann ML
    BMC Cancer; 2014 May; 14():332. PubMed ID: 24885870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site.
    Cotta CV; Coleman JF; Li S; Hsi ED
    Histopathology; 2011 Dec; 59(6):1194-203. PubMed ID: 22175899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
    J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma.
    Møller MB; Pedersen NT; Christensen BE
    Am J Hematol; 2003 Oct; 74(2):94-8. PubMed ID: 14508794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.